Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $61.51M in the twelve months ending March 31, 2024, with 26.65% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $14.50M with 39.22% year-over-year growth. In the year 2023, Theravance Biopharma had annual revenue of $57.42M with 11.84% growth.

• Revenue (ttm): $61.51M
• Revenue Growth: +26.65%
• P/S Ratio: 7.57
• Revenue / Employee: $621,313
• Employees: 99
• Market Cap: 465.42M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	57.42M	6.08M	11.84%
Dec 31, 2022	51.35M	-3.97M	-7.17%
Dec 31, 2021	55.31M	-16.55M	-23.03%
Dec 31, 2020	71.86M	-1.56M	-2.12%
Dec 31, 2019	73.41M	13.04M	21.61%
Dec 31, 2018	60.37M	44.98M	292.37%
Dec 31, 2017	15.39M	-33.26M	-68.37%
Dec 31, 2016	48.65M	6.52M	15.48%
Dec 31, 2015	42.13M	30.44M	260.42%
Dec 31, 2014	11.69M	11.46M	5,071.68%
Dec 31, 2013	226.00K	-129.92M	-99.83%
Dec 31, 2012	130.15M	115.29M	776.16%
Dec 31, 2011	14.85M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.